Growing Market for Smoking Cessation and Nicotine Withdrawal Products

Jul.19.2022
The smoking cessation market has grown with innovations in products and increased awareness of health risks, expected to reach $27.84 billion by 2031.

According to analysis of smoking cessation industry statistics from the past few decades by TMR market research company, the use of smoking cessation products to help smokers quit has increased, primarily including skin patches and oral products. The smoking cessation and nicotine withdrawal market is expected to reach $27.84 billion by 2031. The target audience is becoming more aware of the health burden associated with smoking, as smoking-related illnesses lead to premature deaths every year.


Innovative marketing campaigns that promote the availability and effectiveness of various smoking cessation products have raised awareness of the benefits of quitting smoking, leading to an expansion of the market for tobacco cessation and nicotine replacement companies. National research institutions in the United States and United Kingdom are heavily supporting research on tobacco-related diseases. Due to these factors and market trends, smoking cessation programs in Europe have seen significant growth, expanding the market for smoking cessation products.


A series of studies have emphasized the effectiveness of e-cigarettes in smoking cessation therapy, which has broadened the perspective of the smoking cessation and nicotine withdrawal market. Over the years, the number of young people seeking to quit smoking has significantly increased, which has expanded commercial avenues for gum, lozenges, inhalers, nasal sprays, and nicotine patches. The target audience's understanding of smoking cessation products through online channels has also been increasing, which has promoted the growth of the smoking cessation and nicotine withdrawal market.


The primary findings of the market research on smoking cessation and nicotine withdrawal.


Increased demand for both over-the-counter (OTC) and prescription products, including those designed to alleviate the health burdens of smoking and nicotine, is being driven by a focus on reducing smoking- and nicotine-related health issues. This demand has also spurred growth in the nicotine replacement therapy (NRT) market, which has become an effective tool for smoking cessation and nicotine addiction treatment. Over the past several decades, new smoking cessation aids have been introduced to the market, particularly in the US and UK. Notably, e-cigarettes play a crucial role in smoking cessation, with companies relying on advances in nicotine technology to convince smokers to successfully switch to vaping.


The widespread sales of nicotine replacement therapy (NRT) products driving income growth: For many years, NRT products have been widely adopted in key markets such as the United States. A business intelligence study by TMR found that NRT lozenges, patches, and gum have increased in commercialization in the smoking cessation and nicotine withdrawal market. Additionally, in 2020, NRT product sales saw significant growth in Europe and North America, driving market growth for smoking cessation and nicotine addiction treatment.


Smoking and Nicotine Cessation Market: Key Drivers


The increasing burden of health issues caused by tobacco and nicotine products is a key driver in the market. It is important to note that smoking-related illnesses lead to millions of premature deaths each year.


Electronic cigarettes are becoming increasingly popular and are beneficial for users who want to quit smoking. Their effectiveness is enhanced when used in conjunction with counseling, behavioral therapy, and medication. There is a growing market for smoking cessation products and nicotine replacement therapy (NRT) products that are expanding the avenues for quitting smoking and overcoming nicotine addiction.


In 2020, North America took a leading position in the global smoking cessation and nicotine withdrawal market, with the United States offering significant revenue opportunities for market participants.


Europe is another lucrative market region. Over the years, the implementation of anti-smoking initiatives in certain areas and the rapid adoption of nicotine-containing smoking cessation products have created a significant source of revenue.


The Asia-Pacific region is witnessing a colossal market, and noteworthy is the incredible untapped avenue that manufacturers of NRT (nicotine replacement therapy) products are discovering in the region.


I am sorry, I cannot do that as the original text in unclear. Please provide me with the text you want me to translate.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%
BofA: U.S. Nicotine Market Splits as Vapor Sales Fall 17.2% and Oral Tobacco Rises 5.8%
According to Investing.com citing Bank of America scanner data for the four weeks ending May 30, U.S. nicotine category performance was mixed, with cigarette, vapor and cigar sales declining while oral tobacco sales rose 5.8%.
Jun.10
Special Report|South Korean Lawmaker Queries China Tobacco Regulator Over Synthetic Nicotine as Export-Rule Gaps Emerge
Special Report|South Korean Lawmaker Queries China Tobacco Regulator Over Synthetic Nicotine as Export-Rule Gaps Emerge
A South Korean lawmaker has asked China’s tobacco regulator to clarify rules for e-cigarettes containing synthetic nicotine amid questions over product declarations and possible tax losses. The dispute exposes gaps between Chinese export requirements and destination-market rules, while underscoring the global impact of China’s licensing and traceability policies.
Jul.10
Reuters: Shopify May Ban All Vape Sales This Week Amid Illegal Market Crackdown
Reuters: Shopify May Ban All Vape Sales This Week Amid Illegal Market Crackdown
Reuters reported that Shopify may ban all vape products from its platform as soon as this week, signaling that U.S. enforcement against the illegal vape market is expanding from retailers and importers to e-commerce platforms and payment networks.
MarketBAT
Jun.23 by 2Firsts Perspectives
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
Vuse Alto Adds New U.S. Price Tier as BAT Pushes Deeper Into Mass-Market Vaping
British American Tobacco (BAT) subsidiary Vuse Alto has recently adjusted its price tiers in U.S. convenience store channels, leveraging low-cost device kits and pod promotions to reinforce its positioning in the mid-priced closed-system e-cigarette market.
Jun.17
 BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
British American Tobacco’s London-listed shares rose 13.99% last week, as investors focused on the U.S. Food and Drug Administration’s recent authorization of flavored Glas e-cigarette products, the dismissal of a U.S. sanctions-related criminal case against BAT, and the company’s previously announced share buyback plan and newer nicotine business performance.
BAT
May.18
Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display
Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display
Ireland’s Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026 has passed final stage in the Dáil and will move to the Seanad, with measures to limit vape flavours to tobacco or unflavoured products and tighten rules on packaging colours, retail advertising, in-store displays and sales of nicotine pouches to minors.
News
Jun.26 by 2Firsts Perspectives